Dr. Randy K Moss, PH.D. Psychologist - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 447 N 300 W, Kaysville, UT 84037 Phone: 907-232-5374 Fax: 801-544-3819 |
Kathryn Stewart Neill Psychologist - Clinical Child & Adolescent Medicare: Not Enrolled in Medicare Practice Location: 447 N 300 W Ste 7, Kaysville, UT 84037 Phone: 801-544-7413 |
Dr. Austin M. Chiles Jr., PH.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 447 N 300 W Ste 7, Kaysville, UT 84037 Phone: 801-721-7878 Fax: 801-544-3819 |
Dr. Chris Mcroberts, PH.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 1417 Haight Creek Dr, Kaysville, UT 84037 Phone: 435-830-4058 Fax: 801-451-2011 |
Thomas E. Pritt., PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 475 N 300 W, Suite 14, Kaysville, UT 84037 Phone: 801-529-7982 Fax: 801-544-6558 |
Dr. Kent E. Nabers, PHD. Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 265 North Main Street, Suite D #137, Kaysville, UT 84037 Phone: 801-476-6916 Fax: 801-476-6990 |
News Archive
Clinicians at St. Jude Children's Research Hospital have successfully demonstrated an improved technique for blood stem cell transplantations in children that shows promise for those most likely to fail standard treatment for leukemia.
The New Jersey Assembly Health and Senior Citizens Committee on Thursday approved a bill (A 992) that would require New Jersey's 9,000 licensed pharmacists to fill prescriptions for all drugs, including contraceptives, despite "any sincerely held moral, philosophical or religious beliefs," the Newark Star-Ledger reports (Livio, Newark Star-Ledger, 10/20).
Social media is increasingly popular but engaging in its proper use can prove confusing and challenging - especially in the medical and healthcare arenas. Albert Einstein College of Medicine of Yeshiva University has been awarded a two-year grant to educate faculty members and medical students on using social media appropriately and effectively.
GlycoVaxyn, a pioneer in the development of innovative bioconjugate vaccines, has commenced a Phase I clinical study with its vaccine candidate (GVXN SD133) against Shigella dysenteriae, a cause of serious intestinal infections. This is the first product from the company to enter clinical evaluation.
Johnson & Johnson Wound Management today announced the introduction of SILVERCELâ„¢ antimicrobial alginate dressing, providing the protection of silver and the absorption of alginate.
› Verified 9 days ago